Joseph  Swedish net worth and biography

Joseph Swedish Biography and Net Worth

Insider of Elevance Health
Mr. Swedish is a Co-Founder and Partner at Concord and a member of the Firm’s Investment Committee. Mr. Swedish has more than 45 years of healthcare leadership experience. Most recently, Mr. Swedish was Chairman, President & Chief Executive Officer of Anthem, Inc., a Fortune 29 company and the nation’s leading health benefits provider. He also served for more than 25 years as CEO for several major health systems, most recently Trinity Health, a 22-state integrated health care delivery system. Previously, he was President & CEO of Centura Health, Colorado’s largest health system, and formerly served as Division President for Hospital Corporation of America. Mr. Swedish has been extensively recognized for his leadership in the healthcare field. For 12 years in a row, Modern Healthcare named him one of the 100 Most Influential People in Healthcare, ranking in the top 20 of the health sector’s most senior-level executives, high-level government administrators, elected officials, academics, and thoughts-leaders for five consecutive years. In 2016, Mr. Swedish was one of five health care leaders named to Crain Communications’ Top 100 Innovators list. Mr. Swedish’s commitment to education, public service, diversity and inclusion, and better health care for all extends to his numerous board affiliations. He serves on the board of directors for IBM Corporation, CDW, Mesoblast Limited (chairman), and Centrexion Therapeutics. Also, he has served as chairman and is currently a member of Duke University’s Fuqua School of Business Board of Visitors. Previously, Mr. Swedish served as board chairman of America’s Health Insurance Plans (AHIP), and chairman of the board, Catholic Health Association, a 600-hospital member organization. He has also held board and advisory positions with American Hospital Association (AHA), Coventry Health Care, Inc., RehabCare Group, Inc., BankFIRST, Cross Country, Inc., National Quality Forum, American Hospital Association’s (AHA) Institute for Diversity in Healthcare Management, and Loyola University Chicago.

 

Mr. Swedish received his bachelor’s degree from the University of North Carolina at Charlotte and his master’s (MHA) degree in health administration from Duke University.

What is Joseph Swedish's net worth?

The estimated net worth of Joseph Swedish is at least $41.60 million as of March 5th, 2018. Mr. Swedish owns 84,545 shares of Elevance Health stock worth more than $41,602,058 as of October 6th. This net worth approximation does not reflect any other assets that Mr. Swedish may own. Learn More about Joseph Swedish's net worth.

How do I contact Joseph Swedish?

The corporate mailing address for Mr. Swedish and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Joseph Swedish's contact information.

Has Joseph Swedish been buying or selling shares of Elevance Health?

Joseph Swedish has not been actively trading shares of Elevance Health over the course of the past ninety days. Most recently, Joseph Swedish sold 27,846 shares of the business's stock in a transaction on Monday, March 5th. The shares were sold at an average price of $231.12, for a transaction totalling $6,435,767.52. Following the completion of the sale, the insider now directly owns 84,545 shares of the company's stock, valued at $19,540,040.40. Learn More on Joseph Swedish's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 6 times. They sold a total of 49,986 shares worth more than $25,525,299.90. The most recent insider tranaction occured on August, 5th when Director Ramiro G Peru sold 753 shares worth more than $400,234.56. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 8/5/2024.

Joseph Swedish Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2018Sell27,846$231.12$6,435,767.5284,545View SEC Filing Icon  
2/1/2018Sell64,403$244.37$15,738,161.1184,346View SEC Filing Icon  
1/11/2018Sell67,500$235.87$15,921,225.00134,043View SEC Filing Icon  
12/1/2017Sell21,125$231.43$4,888,958.7587,668View SEC Filing Icon  
11/1/2017Sell21,125$209.85$4,433,081.2587,668View SEC Filing Icon  
10/2/2017Sell21,125$190.63$4,027,058.75View SEC Filing Icon  
9/1/2017Sell21,125$197.00$4,161,625.0087,668View SEC Filing Icon  
12/12/2016Sell8,176$144.10$1,178,161.6075,601View SEC Filing Icon  
11/11/2016Sell24,513$131.48$3,222,969.2487,381View SEC Filing Icon  
7/11/2016Sell8,171$131.49$1,074,404.79112,594View SEC Filing Icon  
6/1/2016Sell11,628$132.02$1,535,128.56124,694View SEC Filing Icon  
5/2/2016Sell11,626$141.19$1,641,474.94137,648View SEC Filing Icon  
4/1/2016Sell11,626$139.38$1,620,431.88169,535View SEC Filing Icon  
1/28/2016Sell11,626$129.47$1,505,218.22182,602View SEC Filing Icon  
12/28/2015Sell11,626$139.47$1,621,478.22194,228View SEC Filing Icon  
See Full Table

Joseph Swedish Buying and Selling Activity at Elevance Health

This chart shows Joseph Swedish's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $492.07
Low: $490.16
High: $501.46

50 Day Range

MA: $535.87
Low: $492.07
High: $562.29

2 Week Range

Now: $492.07
Low: $435.31
High: $567.26

Volume

1,473,893 shs

Average Volume

1,018,150 shs

Market Capitalization

$114.37 billion

P/E Ratio

18.60

Dividend Yield

1.28%

Beta

0.82